How is the Drug-Coated Balloons Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted Annual Growth Rate of the Drug-Coated Balloons Market Over the Coming Decade?
The market for drug-coated balloons has seen a rapid expansion in the last few years. The market value is projected to increase from $1.08 billion in 2024 to $1.24 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.4%. The significant growth witnessed in the historical phase can be linked to factors such as a rise in cardiovascular illness, growing demand for minimally invasive operations, the widespread occurrence of peripheral artery disease (pad), lower rates of restenosis, and advancements in interventional cardiology.
In the coming years, the market for drug-coated balloons is anticipated to experience a swift rise. It is projected to escalate to “$2.22 billion by 2029, with a compound annual growth rate (CAGR) of 15.6%. The projected growth during this period can be accredited to the surge in the aging population, expansion of indications and applications, focus on outpatient and ambulatory care, synergy with drug delivery innovations, and global health initiatives. The predominant trends for this forecast period encompass regulatory approvals for new formulations, a focus on reducing side effects, the emergence of bioresorbable coatings, market growth in emerging economies, and patient-centric approaches.
What External and Internal Drivers Are Contributing to the Growth of the drug-coated balloons Market’s Growth?
An increase in the incidence of coronary artery disease is predicted to stimulate the expansion of the drug-coated balloons market. Coronary artery disease (CAD) is a health issue characterized by the constriction or blockade of the coronary arteries, which supply blood to the heart muscle. This can lead to heart attacks. Drug-coated balloons are medical tools used in the treatment of CAD, releasing a medication into the artery during the procedure to avert restenosis, or a re-narrowing of the artery after angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 by a US-based organization predicted a rise in all four cardiovascular risk factors among the general U.S populace from 2025 to 2060. Diabetes is expected to record the highest percentage increase of 39.3%, followed by dyslipidemia increasing by 27.6%, hypertension by 25.1%, and obesity by 18.3%. The study also found heart failure (33.4%) and ischemic heart disease (30.7%) to have the largest projected rate increases, followed by heart attack (16.9%) and stroke (33.8%). As such, the increasing occurrence of coronary artery disease is predicted to fuel the growth of the drug-coated balloon market.
Get Your Free Sample of the Global Drug-Coated Balloons Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp
What Are the Major Players Making an Impact in the Drug-Coated Balloons Market’s Growth?
Major companies operating in the drug-coated balloons market include:
• Acotec Scientific AG_x000D_
• B. Braun Melsungen AG_x000D_
• Biosensors International Group Ltd_x000D_
• Medtronic Inc._x000D_
• Boston Scientific Corporation_x000D_
Which Upcoming Trends Are Set to Influence the Drug-Coated Balloons Market’s Path Forward?
One major trend gaining traction in the drug-coated balloon market is product innovation. Companies in this market are constantly working on developing groundbreaking and innovative technological solutions to solidify their industry presence. For example, Becton, Dickinson, and Company (BD), a medical technology firm based in the US, kicked off the PREVISION first-in-human trial in August 2022. This particular trial involves a peripheral sirolimus drug-coated balloon (DCB) and aims to evaluate its safety and efficacy in treating patients with peripheral artery disease, a condition that severely affects mobility and quality of life.
Get Instant Access to the Global Drug-Coated Balloons Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report
Which Segments of the Drug-Coated Balloons Market Hold the Most Potential for Future Development?
The drug-coated balloons market covered in this report is segmented –
1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers
Subsegments:
1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons
3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications
What Regions Are Steering Growth in the Drug-Coated Balloons Sector?
North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Can We Define the Drug-Coated Balloons Market and Its Key Components?
A drug-coated balloon (DCB) is a medical device used in the treatment of narrowed or blocked blood vessels, primarily in the field of interventional cardiology and interventional radiology. It is designed to deliver medication directly to the site of vascular disease while simultaneously performing angioplasty.
Browse Through More Similar Reports By The Business Research Company:
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
Pain Management Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
